Your partner in the fight against depression
Welcome to TMS of Alabama
We specialize in NeuroStar TMS, the safest, most effective non-drug treatment for depression.
about transcranial magnetic stimulation (TMS)
The Problem
An Effective Solution
Traditional Methods
Over 21 million Americans suffer from major depressive disorder. An estimated 6.4 million have tried antidepressants without success. In fact, the largest prospective clinical trial of major depressive disorder ever conducted, the STAR*D study showed that a patient’s chance for remission decreases with each subsequent medication attempt.
Traditional Methods
An Effective Solution
Traditional Methods
If you’re like so many who suffer from depression, you have tried multiple medications or therapies searching for relief. These treatments don’t deliver satisfactory results for everyone, and they often come with significant side effects that only add to the struggle. It can be an exhausting cycle of trial and error that feels never ending.
An Effective Solution
An Effective Solution
An Effective Solution
TMS is Transcranial Magnetic Stimulation therapy, a non-drug treatment for major depression. TMS uses focused magnetic pulses, similar to an MRI, to reignite dormant synapses in the brain and help your brain function the way it was meant to.
It is not a drug, “shock” therapy, or surgery. It is a safe, effective treatment for MDD without the common side effects of medication.
About Neurostar: Our Partner in TMS
The Physician’s Choice
Proven Depression Relief
Proven Depression Relief
NeuroStar is the #1 physician-recommended TMS treatment, with over 6.1 million treatments performed, in over 169,000 people.
Proven Depression Relief
Proven Depression Relief
Proven Depression Relief
A real-world study reported an 83% response rate. This means that 83% of patients that completed their NeuroStar treatment cycle saw measurable improvement in their depression symptoms.
Results That Last
Proven Depression Relief
Results That Last
NeuroStar is the only TMS therapy with demonstrated durability in treatment resistant depression patients through one year.